Device of Tomorrow Capital - aVenture Asset Manager Research
Device of Tomorrow Capital
Operating Status: Operating
Investing in cutting-edge medical devices and technologies for tomorrow's healthcare.
Location
Anaheim, CA, US
Device of Tomorrow Capital is an investment firm based in Anaheim, California, focusing on high-growth potential medical devices and medical technology companies. The firm targets investments at various stages, including Pre-Seed, Seed, Series A, and Series B rounds. Their investment philosophy emphasizes value investment and the strategic timing of investments to support startups that are working on major technological breakthroughs with significant market potential.
Notable portfolio companies include Cari Health, Carlsmed, Centerline Biomedical, Laplace Labs, and Telesair. The firm is led by key partners with extensive experience in the medical technology sector. Device of Tomorrow Capital offers unique value-add services to its portfolio companies, such as strategic guidance and industry connections, to help drive innovation and growth in the healthcare infrastructure.
Device of Tomorrow Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies6
Current Portfolio Count6
Top Investment Stages
Seed2 (33.3%)
Series A2 (33.3%)
Pre-Seed1 (16.7%)
Series B1 (16.7%)
Stage Mix
Seed 33%Series A 33%Pre-Seed 17%Series B 17%
Concentration shown as share of disclosed investments by stage.
